Esperanza Arias
Affiliations: | Pharmacology | Universidad Autónoma de Madrid, Madrid, Comunidad de Madrid, Spain |
Area:
neuroprotectionGoogle:
"Esperanza Arias"Mean distance: 20.73 (cluster 28) | S | N | B | C | P |
Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382 |
| Arias E, Gallego-Sandin S, del Barrio L, et al. (2006) P4-295: Neuroprotective effects of acetylcholinesterase inhibitors Alzheimer's & Dementia. 2: S603-S604 |
| Gallego-SandÃn S, Novalbos J, Rosado A, et al. (2005) Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. European Journal of Pharmacology. 520: 1-11 |
| Arias E, Gallego-SandÃn S, Villarroya M, et al. (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 315: 1346-53 |
| Orozco C, de Los Rios C, Arias E, et al. (2004) ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties. The Journal of Pharmacology and Experimental Therapeutics. 310: 987-94 |
| Arias E, Alés E, Gabilan NH, et al. (2004) Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology. 46: 103-14 |